Merck & Co., Inc. (MRK) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $132.92 --0%
Financial Fact:
Total Costs, Expenses and Other: 12.82B
Today's EPS Names:
AFIB, VAXX, NMRD, More
Financial Fact:
Total Costs, Expenses and Other: 12.82B
Today's EPS Names:
AFIB, VAXX, NMRD, More
Join SI Premium – FREE
Merck & Co., Inc. (NYSE: MRK) reported Q2 EPS of $1.05, $0.04 better than the analyst estimate of $1.01. Revenue for the quarter came in at $12.2 billion versus the consensus estimate of $12.16 billion.
For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.
For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
- AIRO Group Holdings, Inc. (AIRO) Reports Q2 Loss of $0.06
- Global Water Resources (GWRS) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
